|
1 Indications And Usage Biktarvy Is Indicated As A Complete Regimen For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection In Adults And Pediatric Patients Weighing At Least 25 Kg Who Have No Antiretroviral Treatment History Or To Replace The Current Antiretroviral Regimen In Those Who Are Virologically-Suppressed (Hiv-1 Rna Less Than 50 Copies Per Ml) On A Stable Antiretroviral Regimen With No History Of Treatment Failure And No Known Substitutions Associated With Resistance To The Individual Components Of Biktarvy. Biktarvy Is A Three-Drug Combination Of Bictegravir (Bic), A Human Immunodeficiency Virus Type 1 (Hiv-1) Integrase Strand Transfer Inhibitor (Insti), And Emtricitabine (Ftc) And Tenofovir Alafenamide (Taf), Both Hiv-1 Nucleoside Analog Reverse Transcriptase Inhibitors (Nrtis), And Is Indicated As A Complete Regimen For The Treatment Of Hiv-1 Infection In Adults And Pediatric Patients Weighing At Least 25 Kg Who Have No Antiretroviral Treatment History Or To Replace The Current Antiretroviral Regimen In Those Who Are Virologically Suppressed (Hiv-1 Rna Less Than 50 Copies Per Ml) On A Stable Antiretroviral Regimen With No History Of Treatment Failure And No Known Substitutions Associated With Resistance To The Individual Components Of Biktarvy. ( 1 )
|